FDA Grants Approval for Lacosamide ANDA217596
The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 217596 for lacosamide.
Asset / Drug
Drug and asset intelligence for epilepsy with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.